Search clinical trials for: 0.9% NaCl

Total 5280 results

Tianjin Medical University General Hospital

Recruiting

Normal Saline Infusion for Stroke After Intravenous Thrombolysis (NS-STAR)

Brain Infarct

China
University Hospital Inselspital, Berne

Completed

Hypertonic Saline for Fluid Resuscitation After Cardiac Surgery (HERACLES)

Cardiovascular Diseases | Valvular Heart Disease

Switzerland
Carmel Medical Center

Unknown

IV NaCl (Sodium Chloride) 0.9% Vs (Versus) IV NaCl 0.9% + 5% Dextrose in Pediatric ER for Dehydration

Dehydration

Israel
Atox Bio Ltd
Biomedical Advanced Research and Development Authority

Completed

Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections (ACCUTE)

Necrotizing Fasciitis | Necrotizing Soft Tissue Infections | Fournier's Gangrene

United States, France
Aydin Adnan Menderes University

Completed

Effects of Fluid Infusion on Postoperative Vomiting in Pediatric Patients Undergoing Otorhinolaryngological Surgery (FLUIDVOMIT)

Postoperative Nausea and Vomiting

Turkey
Ahmad Jabir Rahyussalim

Unknown

Effectivity of Mesenchymal Stem Cell on Vertebral Bone Defect Due to Mycobaterium Tuberculosis Infection

Mesenchymal Stem Cell | Spinal Tuberculosis

Indonesia
The Hospital for Sick Children

Terminated

Effects of Saline on Circulation in Children

Pulmonary Hypertensive Crisis

Canada
Meshalkin Research Institute of Pathology of Circulation

Completed

The Efficacy and Safety of Hypertonic Saline in Cardiac Surgery Patients. (ESHHS)

Coronary Artery Disease | Edema

Russian Federation
Visirna Therapeutics HK Limited

Not yet recruiting

A VSA003 Phase 1 Study in Chinese Adult Healthy Volunteers

Dyslipidemias | Hypertriglyceridemia | Familial Hypercholesterolemia
University of Messina

Completed

Polydeoxyribonucleotide -Placentex Mastelli(Pdrn) for the Treatment of Diabetic Ulcers

Diabetic Ulcer | Foot Ulcer Unhealed

Italy
Noveome Biotherapeutics, formerly Stemnion

Completed

Safety, Efficacy and Treatment Regimen Study of ST266 in Subjects With Moderate to Severe Periodontitis

Periodontal Disease

United States
NHS Greater Glasgow and Clyde
University of Glasgow; Aurum Biosciences Ltd

Unknown

Perfluorocarbon (ABL-101) Oxygenation for Stroke: Trial With GOLD (Glasgow Oxygen Level Dependent Technology) Imaging Theranostic (POST-IT)

Acute Ischaemic Stroke
Oslo University Hospital
University of Oslo; Norwegian University of Science and Technology; St. Olavs... and other collaborators

Completed

ASSessing the Effect of Anti-IL-6 Treatment in Myocardial Infarction: The ASSAIL-MI Trial (ASSAIL-MI)

Myocardial Infarction | Coronary Disease

Norway
University Hospital, Basel, Switzerland
Fresenius AG

Completed

BaSES Trial: Basel Starch Evaluation in Sepsis (BaSES)

Sepsis | Septic Shock | Severe Sepsis

Switzerland
Phramongkutklao College of Medicine and Hospital

Unknown

Efficacy of KCl Plus 0.9%NaCl Compare With KCl Plus 0.45%NaCl

Hypokalemia

Thailand
Hamilton Health Sciences Corporation

Completed

Hypotonic Versus Isotonic Parenteral (HIP) Fluid Trial

Hyponatremia | Hypernatremia

Canada
Second Affiliated Hospital, School of Medicine,...
Second Affiliated Hospital of Wenzhou Medical University; Zhejiang University; Red Cross Hospital, Hangzhou, China and other collaborators

Terminated

Efficacy and Safety of Salvianolic Acid on AIS

Stroke

China
University of Arkansas

Recruiting

Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence

Squamous Cell Carcinoma of Head and Neck

United States
Suzhou Municipal Hospital of Anhui Province
Xuanwu Hospital, Beijing

Recruiting

Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment (IRIS)

Ischemic Stroke | Endovascular Treatment | Interleukin-6

China
University Hospital, Strasbourg, France

Completed

Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility Study (PlasmaFaisa)

Septic Shock | Coagulopathy | Disseminated Intravascular Coagulation

France
Alteogen, Inc.

Completed

Clinical Study of ALT-BB4 to Determine Tolerance, Safety and Pharmacokinetics in Healthy Volunteer

Health, Subjective

Korea, Republic of
Ain Shams University

Active, not recruiting

Ratio of ''Central Venous-to-Arterial Co2 Gap'' to ''Arterial-to-Central Venous O2 Content Gap'' in Septic Shock

Septic Shock

Egypt
Nantes University Hospital

Completed

Continuous Regional Analgesia After Total Knee Arthroplasty

Analgesia

France
Vasopharm GmbH

Completed

Phase 2 a Study to Assess Safety and Pharmacokinetics of VAS203 in Patients With Traumatic Brain Injury (NOSTRA)

Traumatic Brain Injury

Austria, France, Spain, Switzerland, United Kingdom
Guerbet

Completed

Pharmacokinetics, Pharmacodynamics Profile and Tolerance of P03277 in Healthy Subjects and Patients With Brain Lesions

Healthy Volunteers | Brain Lesion

Belgium
BMI Korea

Completed

Evaluate the Safety and Tolerability of a Single-dose Administration of BMI2004 Inj.

Health, Subjective

Korea, Republic of
University Hospital Muenster
Vifor Pharma

Terminated

Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery (PRIVIRON)

Anemia | Orthopedic Surgery | High Risk of Blood Loss

Germany
University Hospital Inselspital, Berne
Roche Pharma AG

Terminated

Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19) (CORON-ACT)

SARS-CoV-2 Infection

Switzerland
University Hospital, Basel, Switzerland

Completed

Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues (SKIP)

Smoking Cessation | Craving | Weight Change, Body | Glucagon-like Peptide-1

Switzerland
AIM Vaccine Co., Ltd.
Ningbo Rongan Biological Pharmaceutical Co. Ltd.; LiveRNA Therapeutics Inc.; AIM...

Recruiting

A Global Multi-center Clinical Study of SARS-CoV-2 mRNA Vaccine for the Prevention of COVID-19

SARS-CoV-2

Kenya
Polyheal Ltd.

Unknown

Study to Evaluate Polyheal-1 in Treatment of Recalcitrant Wounds

Wounds and Injuries

Israel
University of Haifa
Western Galilee Hospital-Nahariya

Recruiting

Physiological, Cognitive, and Personal Features in the Link Between Placebo-effect and Variability of Pain Reports

Chronic Back Pain

Israel
Alnylam Pharmaceuticals

Completed

A Safety and Tolerability Study of an Investigational Drug, ALN-TTRSC02, in Healthy Subjects

Transthyretin-mediated Amyloidosis (ATTR Amyloidosis)

United Kingdom
Alnylam Pharmaceuticals
The Medicines Company

Completed

A Phase 1 Study of an Investigational Drug, ALN-PCSSC, in Subjects With Elevated Low Density Lipoprotein Cholesterol (LDL-C)

Hypercholesterolemia

United Kingdom
Alnylam Pharmaceuticals

Completed

Trial to Evaluate Safety, Tolerability, and Parmacokinetics of ALN-TTR02 in Healthy Volunteer Subjects

TTR-mediated Amyloidosis

United Kingdom
Alnylam Pharmaceuticals

Completed

Trial to Evaluate Safety and Tolerability of ALN-PCS02 in Subjects With Elevated LDL-Cholesterol (LDL-C)

Elevated LDL-Cholesterol (LDL-C)

United Kingdom
Alnylam Pharmaceuticals

Completed

Trial to Evaluate Safety and Tolerability of ALN-TTR01 in Transthyretin (TTR) Amyloidosis

Transthyretin Mediated Amyloidosis (ATTR)

United Kingdom, France, Portugal, Sweden
Arrowhead Pharmaceuticals

Completed

Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients

Dyslipidemias | Hypertriglyceridemia | Familial Hypercholesterolemia

Australia, New Zealand
Arrowhead Pharmaceuticals

Completed

Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS)

Hypertriglyceridemia | Familial Chylomicronemia

Australia, Canada, New Zealand
Alnylam Pharmaceuticals

Completed

A Phase 1/2 Study of an Investigational Drug, ALN-CC5, in Healthy Adult Volunteers and Patients With PNH

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Spain, United Kingdom
Karolinska Institutet
Danderyd Hospital

Completed

Endotoxin-induced Inflammatory and Behavioral Responses and Predictors of Individual Differences

Sickness Behavior
Alnylam Pharmaceuticals

Completed

ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC)

Amyloid Neuropathies | Amyloid Neuropathies, Familial | Amyloidosis, Hereditary | Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC) | Amyloidosis, Hereditary, Transthyretin-Related | Familial Transthyretin Cardiac Amyloidosis

United States, France, Italy, Spain, Canada, Germany, Belgium, Sweden, United Kingdom
Alnylam Pharmaceuticals

Completed

A Phase 1 Study of Givosiran (ALN-AS1) in Patients With Acute Intermittent Porphyria (AIP)

Acute Intermittent Porphyria

United States, United Kingdom, Sweden
The First Affiliated Hospital with Nanjing Medical...

Unknown

Ad-HGF Treatment for Myocardial Infarction

Myocardial Infarction
Huro Biotech Joint Stock Company
Thai Binh University of Medicine and Pharmacy

Completed

Safety Evaluation of Intranasal Use of DSM 32444 Postbiotic in Humans

Rhino Sinusitis

Vietnam
IRCCS Burlo Garofolo

Completed

Nasal Irrigation in Infants With Bronchiolitis.

Bronchiolitis

Italy
Virginia Commonwealth University

Withdrawn

Pharmacokinetic Profile and Dermatomal Coverage of the Erector Spinae Plane Block

Pain, Postoperative | Pain, Chest

United States
Ceylan Saygili
Istanbul University - Cerrahpasa (IUC)

Completed

Comparison of Oblique Subcostal, Posterior or Dual Transversus Abdominis Plane Block in Laparoscopic Cholecystectomy

Cholelithiasis | Laparoscopic Cholecystectomy | Postoperative Analgesia

Turkey
Alnylam Pharmaceuticals

Completed

APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis

Amyloid Neuropathies | Amyloid Neuropathies, Familial | TTR-mediated Amyloidosis | Amyloidosis, Hereditary | Amyloidosis, Hereditary, Transthyretin-Related | Familial Amyloid Polyneuropathies

United States, Canada, Argentina, Australia, Bulgaria, Cyprus, Italy, Japan, Malaysia, Mexico, Netherlands, Portugal, Spain, Sweden, Germany, France, Brazil, Turkey, Korea, Republic of, Taiwan, United Kingdom
Alnylam Pharmaceuticals

Completed

A Phase 1, Single- and Multi-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered ALN-TTRSC (Revusiran) in Healthy Volunteers

TTR-mediated Amyloidosis

United Kingdom

Search clinical trials for: 0.9% NaCl

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations